Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Berberine Hydrochloride and Bifidobacterium in Diabetes Mellitus Prevention and Treatment：an Open-label, Multicenter，Randomized, Prospective，Controlled Study

NCT02084004 is registered in ClinicalTrials.gov with Xijing Hospital as lead sponsor.

NCT NCT02084004
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02084004 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Berberine Hydrochloride and Bifidobacterium in Diabetes Mellitus Prevention and Treatment：an Open-label, Multicenter，Randomized, Prospective，Controlled Study
Lead sponsor
Xijing Hospital
Phase
Phase 2/3
Overall status
Withdrawn
Start date
November 30, 2015
Completion date
April 30, 2018
Enrollment
0 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes mellitus